Bone Biologics Corporation

Healthcare · Biotechnology · United States

Last price 0.3883 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.07M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or b...